DIRECT-TO-CONSUMER Rx DRUG ADVERTISING DOES NOT NECESSARILY IMPLY HIGHER PRICES AND COULD LEAD TO DECREASES, FTC ECONOMIST TELLS DIA ANNUAL MEETING

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".